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In the kidney, lesions mediated by antibodies against glomerular basement 
membrane antigens or by circulating or in situ-formed immune complexes have 
been extensively studied. Much less is known about similar pathogenic mecha- 
nisms in the lung. In laboratory animals it appears difficult to induce antibody- 
mediated pneumonitis. The  endothelium of the alveolar  capillary  wall  is,  in 
contrast to  that of the glomerular capillary wall, nonfenestrated. It has been 
proposed that this type of endothelium prevents easy access of macromolecules 
such as IgG or immune complexes to the alveolar basement membrane (ABM) t 
(1). Support for this view has come from experiments in rabbits (1) and in rats 
(2) where it was found that under normal physiological conditions heterologous 
antibodies against ABM do not bind to this structure. If, however, the endothe- 
lium is damaged by exposure of animals to  100%  oxygen, both heterologous 
antibodies (1,  2) and autologous IgG (1)  localize along the ABM  and induce 
pneumonitis. 
In patients with Goodpasture's disease there is evidence that autoantibodies 
reacting with the ABM cause hemorrhagic pneumonitis. However, the sequence 
of events resulting in this injury is not clearly defined (3).  Patients with high 
concentrations of serum antibodies strongly reacting with ABM in vitro may not 
develop signs of lung injury. In contrast, patients with low levels of antibodies 
* Supported by Grant AI-10334 of the  National Institute of Allergy and Infectious  Diseases, 
National Institutes of Health, United States Public Health Service, and by Grants from the American 
Heart Association, the Joe and Emily Lowe Foundation,  and the Dana Foundation. Part of this study 
was presented at the 67th Annual Meeting of the Federation of American Societies for Experimental 
Biology, Chicago, IL, 1983. 
1  Abbreviations used in this  paper:  ABM,  alveolar basement membrane; ACE, angiotensin-convert- 
ing enzyme; Gt, goat; HRP, horseradish  peroxidase;  IF, immunofluorescence;  KLH, keyhole limpet 
hemocyanin; PBS, phosphate-buffered saline; Rb, rabbit. 
J. Exe. MED. © The Rockefeller University Press • 0022-1007/83/12/2141/18 $1.00  2141 
Volume 158  December 1983  2141-2158 2142  LUNG  INJURY  MEDIATED  BY  ANTIBODIES  TO  ENDOTHELIUM 
reacting weakly with ABM in vitro occasionally develop fulminating lung disease 
(3-5). The pulmonary component of Goodpasture's disease is often precipitated 
by  secondary  events  such  as  infections  (5). These  observations  in  man  are 
consistent with  the  hypothesis that  factors increasing the  permeability of the 
alveolar  capillary  wall  have  an  important  role  in  the  induction  of antibody- 
mediated lung disease. 
The aim of the present study was to explore the effects of the interaction of 
antibodies with the endothelium of the alveolar capillary wall.  To this purpose 
rabbits were repeatedly injected with heterologous antibodies specific for angi- 
otensin-converting  enzyme  (ACE),  a  well-defined  antigen  expressed  on  the 
plasma membrane of lung endothelial cells (6,  7).  It was found that on the first 
day  of injection,  anti-ACE  antibodies  induce  fatal  pulmonary edema  in  the 
majority of rabbits and cause redistribution of ACE on the plasma membrane of 
alveolar capillary wall endothelial cells and local fixation of complement. Contin- 
ued administration of antibodies to surviving rabbits resulted in disapperance of 
ACE from the surface of lung endothelial cells.  This "immunological enzymec- 
tomy" appeared to render the rabbits refractory to the damaging effects of anti- 
ACE antibodies. The results indicate that IgG antibody reacting in vivo with an 
antigen expressed on the plasma membrane of lung endothelial cells causes an 
antigenic modulation similar to that observed in other systems characterized by 
interaction of plasma membrane receptors with soluble ligands. The clinical and 
immunopathological events appear relevant for the understanding of the path- 
ogenesis of antibody-mediated injury in the lung and, probably, in other organs. 
Materials and Methods 
Animals.  Female  New  Zealand  white  rabbits  (Beckens Farms,  Sanborn,  NY), each 
weighing 2.5-3 kg, were used. They were allowed free access to water and Purina rabbit 
pellets. 
Goat Anti-rabbit ACE (Gt Anti-RbACE) Antibody Preparations.  Rabbit pulmonary ACE 
was purified  by a modification of earlier published  methods (8, 9).  Frozen rabbit  lungs 
(PeI-Freeze Biologicals, Rogers, AR) were homogenized  in a buffer containing  20 mM 
Tris-HCl,  pH  7.8,  30  mM KCI, 5 mM magnesium acetate,  and 0.025  M sucrose and 
centrifuged at  16,000g for 1 h. The pellet was dispersed in  10 mM Tris-HCl,  pH 7.8, 
and 0.5% Nonidet-P40,  stirred  vigorously for 3 h, and centrifuged at 16,000g for 1 h. 
The resulting supernatant containing solubilized enzyme was mixed with a slurry of DEAE 
cellulose equilibrated  in  10  mM potassium phosphate,  pH 6.5,  0.5% Nonidet-P40  and 
filtered. The filter cake was resuspended in potassium phosphate buffer containing 0.025% 
Nonidet-P40, mixed, and refiltered.  The enzyme was eluted with 0.2 M and 0.35 M KCI 
containing 0.025%  Nonidet-P40,  concentrated, dialyzed extensively in 1 mM potassium 
phosphate,  pH  7.5,  0.025%  Nonidet-P40,  and sequentially fractionated  in a series of 
negative adsorption steps with calcium phosphate gel. The concentrated eluate was diluted 
with 10 mM Tris-HCI, pH 7.8, reconcentrated six times to eliminate residual detergent, 
and then applied to a Sephadex G-200 column under vacuum. Two peaks of activity in 
the eluate were combined and the final purification step was performed with a glycerol 
gradient (5-20%  in  10mM Tris-HCl) run at 38,000  rpm,  with a Beckman SW 40  Ti 
rotor, for 18 h at 4°C in a Beckman L2-65B ultracentrifuge (Beckman Instruments,  Inc., 
Spinco Div., Palo Alto, CA). The activity was resolved in a single peak that was assayed 
according to the method of Cushman and Cheung (10). The protocol resulted in a 1,000- 
fold purification  with a final specific activity consistent with previous experience  (8,  9, 
11). The purified enzyme showed a single band on polyacrylamide gel electrophoresis 
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Antibodies to RbACE were raised in goats by immunization with the purified enzyme 
in complete Freund's adjuvant (11).  In all experiments the same pool of Gt anti-RbACE 
77-globulin isolated by ammonium sulfate precipitation was used. Isolation of IgG from 77- 
globulin  was  achieved by fractionation by DEAE cellulose chromatography (12).  The 
pooled IgG fractions were dialyzed in 0.1  M sodium acetate, pH 4.5, and treated with 
pepsin (Sigma Chemical Co., St. Louis, MO) at a ratio of 1 mg pepsin/100 mg protein at 
37°C for 18 h (13).  The digest was centrifuged and divided into two aliquots. The first 
aliquot was dialyzed in 0.1  M Tris-HCl, 0.2 M NaCI, 2 mM EDTA, pH 7.8, and applied 
to a 4-cm ×  100-cm column of Sephacryl S-200 (Pharmacia Fine Chemicals, Piscataway, 
NJ) at a  flow rate of 11  mi/h.  The F(ab')2 was  recovered in the second protein peak, 
concentrated, dialyzed in phosphate-buffered saline (PBS), and then applied to a column 
of Protein A  Sepharose CL4B (Pharmacia) in  0.1  M  sodium phosphate, pH  7.6.  The 
second aliquot of pepsin digest was  dialyzed in 0.1  M  sodium phosphate, pH  7.5, and 
treated with papain (Sigma), at a ratio of 1:100 (wt/wt) in the presence of 1 mM EDTA 
and 10 mM L-cysteine at 37°C for 18 h (14). The digestion was terminated with iodacetic 
acid at a final concentration of 15 mM. The digest was dialyzed in 0.1  M Tris-HCl, 0.2 
M NaCI, 2 mM EDTA, pH 7.8, and applied to the Sephacryl S-200 column as described. 
The eluted Fab was recovered from the third protein peak, dialyzed in PBS, and applied 
to a column of Protein A Sepharose as described above. There was no detectable IgG in 
either the F(ab')2 or the Fab preparations as determined by polyacrylamide gel electro- 
phoresis with a loading of 100 ~g protein, Both F(ab')~  and Fab gave single arcs against 
Rb anti-GtlgG by immunoelectrophoresis in agarose. IgG and F(ab')~  formed precipitin 
bands against purified converting enzyme by the Ouchterlony immunodiffusion technique, 
whereas Fab did not. 
Preparation of Radiolabeled Antibodies to Rabbit ABM and to Keyhole Limpet Hemocyanin 
(KLH).  Rabbit ARM was prepared according to a modification (1) of a method described 
by Meezan  et al.  (15).  Rabbit  lung pairs were purchased from PeI-Freeze Biologicals. 
Purified KLH was obtained from Calbiochem-Behring Corp., San Diego, CA. Antisera to 
rabbit ARM and KLH were raised in rats by immunization with the antigenic preparations 
in complete Freund's adjuvant. The 7-globulin fraction of the immune sera was isolated 
by ammonium sulfate precipitation. The rat anti-RbABM and anti-KLH antibodies were 
purified from the 77-globulin preparations by affinity column chromatography with the 
antigens coupled to cyanogen bromide-activated Sepharose 4 B (Pharmacia Fine Chemi- 
cals).  The purified antibody preparations were iodinated by the chloramine-T method 
(16). 
Design of  Experiments.  A.  Rabbits treated with intravenous injections of Gt anti-RbACE 
77-globulin: (a) 49 normal rabbits were started on a daily schedule of 3 doses of 7 mg of 
Gt anti-RbACE 77-globulin in 3 ml of PBS, injected in a lateral ear vein for a maximum 
of 4 d.  1  5 normal rabbits were similarly injected with normal Gt 77-globulin. At autopsy 
of rabbits that died or were sacrificed, fragments of lung, kidney, liver, spleen, adrenal, 
and choroid plexus were removed for immunopathologic studies. Before processing, lungs 
were inflated with a solution of 0.5% bovine serum albumin in PBS delivered via a cannula 
inserted in the trachea (1). (b) 1  5 rabbits were depleted of polymorphonuclear leukocytes 
by the administration of 1.75 mg/kg body weight of NH~ (Mustargen HCI, Merck, Sharp 
and Dohme, West Point, PA) (1 7). These rabbits were then also started on a schedule of 
3 intravenous doses of 7 mg of Gt anti-RbACE 77-globulin per day. 
B.  Rabbits  injected with  horse radish  peroxidase (HRP)-labeled Gt anti-RbACE  3'- 
globulin: Immunoelectron microscopic studies were performed according to a methodol- 
ogy proposed by Vogt et al.  (18) and modified by Abrahamson and Caulfield (19).  One 
normal and  one polymorphonuclear leukocyte-depleted rabbit  were intravenously in- 
jected, over a  5-h period, with  20  mg of HRP-labeled Gt anti-RbACE 77-globulin. As 
controls, one polymorphonuclear leukocyte-depleted rabbit was injected with 20 mg of 
HRP-labeled normal Gt v-globulin and another polymorphonuclear leukocyte-depleted 
rabbit was injected simultaneously with 20 mg of unlabeled Gt anti-RbACE 77-globulin 
and 20 mg of HRP-labeled normal Gt 77-globulin. After completion of the injections, the 
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(see below). The -),-globulin preparations were labeled with HRP as described by Nakane 
and Kawaoi (20). 
C.  Rabbits injected with Gt anti-RbACE IgG, or F(ab')~ or Fab fragments of Gt anti- 
RbACE IgG: One rabbit received 52 mg of Gt anti-RbACE IgG, two rabbits 18 mg each 
of Gt anti-RbACE  F(ab')2, and three rabbits 25  mg each of Gt anti-RbACE Fab.  The 
injections were given intravenously over a period of 5 h. After termination of the injection, 
the animals were sacrificed and various organs were immediately removed for immuno- 
pathologic studies.  In two additional  rabbits the  injection  in one of 25  mg of Gt anti- 
RbACE Fab and in the other of 25 mg of Fab fragments of normal GtIgG was followed 
by the  intravenous  administration  over a  15-rain  period  of 3  ml of a  Rb anti-GtIgG 
antiserum (Cappel Laboratories, Cochranville, PA). These latter two animals were sacri- 
riced 10 min later. 
D.  Rabbits to which, following a single injection of Gt anti-RbACE ~,-globulin,  radio- 
labeled-rat anti-RbABM antibodies were administered:  Immediately following an intra- 
venous injection of 7 mg of Gt anti-RbACE "),-globulin, seven rabbits received a mixture 
of ~e'~I-labeled, purified  rat anti-RbABM  antibodies and  13q-labeled,  purified  rat anti- 
KLH antibodies. The animals were sacrificed half an hour later and their lungs, livers, 
and kidneys prepared for measurement of the specific uptake of the anti-ABM antibodies 
(1). Seven other rabbits were similarly treated, except that instead of Gt anti-RbACE 7- 
globulin they were injected with 7  mg of normal Gt 7-globulin. The specific uptake of 
the  anti-ABM  antibodies  in  various  organs  was  calculated  as  described  in  an  earlier 
publication (1). For statistical analysis, the Student's t-test was used. 
Determination of  ACE Activity in Serum, and in Lung and Kidney Tissue Homogenates.  After 
removal of standardized sized specime~ls  from lung (one specimen from each lobe) and 
kidney for immunopathologic studies, the remaining tissue was homogenized in PBS and 
assayed for ACE activity according to the method of Cushman and Cheung (10).  ACE 
activity was also determined in serum samples obtained before sacrifice of the rabbits. 
Immunofluorescence (IF) Microscopy.  Direct IF tests on tissues obtained at autopsy of all 
rabbits were performed according to methods described in an earlier publication (21). 
FITC-conjugated antisera to GtIgG, RblgG, RbC3, and Rbfibrin were purchased from 
Cappel Laboratories. They were found to be monospecific by immunoelectrophoresis as 
well as by immunodiffusion. Gt anti-RbACE IgG was conjugated with FITC by a standard 
method  (21).  To  determine  whether  polymorphonuclear  leukocytes  were  present  in 
sections of frozen  lung  tissue  from  NH2-treated  rabbits  that  died  on  the  first day of 
administration  of Gt anti-RbACE  7-globulin,  an  FITC-conjugated antiserum to rabbit 
polymorphonuclear leukocyte cationic proteins was used. This antiserum was prepared as 
described  in an earlier publication  (22).  In indirect  IF tests frozen sections of normal 
rabbit tissues were incubated with serial dilutions of Gt anti-RbACE and normal Gt 3'- 
globulin  preparations,  followed by incubation  with  FITC-labeled antiserum  to GtIgG. 
Sections for IF microscopy were examined with Leitz Ortholux microscope equipped with 
epifluorescence optics and appropriate filters for FITC. 
Light Microscopy.  Tissue specimens removed at autopsy were fixed in  10%  buffered 
formalin and embedded in paraffin. 3-t~m thick sections were stained wtih hematoxylin- 
eosin and periodic acid Schiff. 
Electron Microscopy.  Fragments of lung and kidney tissue were fixed by submersion in 
Karnovsky's fixative (23), postfixed in 1% osmium tetroxide, and embedded in Epon 812- 
Araldite. Perfusion-fixation of the lungs was not performed to avoid removal of inflam- 
matory cells  from vascular lumina.  Thin  sections stained  with  uranyl acetate and  lead 
citrate were examined with a JEOL 100S electron microscope. 
hnmunoelectron Microscopy.  Fragments of lung of rabbits injected with HRP-iabeled 7- 
globulin  preparations were fixed by submersion  in  Karnovsky's fixative.  ,~40  micron- 
thick sections of lung were obtained using a  Smith-Farquhar tissue chopper.  HRP was 
visualized by incubation of the sections in  diaminobenzidine hydrochloride (Sigma) fol- 
lowed by addition of 0.003% H202 (24).  The sections were "flat embedded" in Epon 812- 
Araldite and thin sectioned for electron microscopy (25). BARBA ET  AL.  2145 
Results 
In  Vitro Reactivity  of the GT Anti-RbACE Preparations.  Testing of the Gt anti- 
RbACE preparations  in vitro by indirect  IF microscopy showed the following 
reactivity: linear binding of GtIgG,  F(ab')~,  and Fab along the endothelium of 
alveolar capillaries of the lung (Fig. 1 A), of capillaries of the choroid plexus (Fig. 
2A), of periportal vessels of the liver, and, though weakly, of the sinusoidal wall 
of the adrenal; in addition, binding was observed to the brush border of proximal 
tubules of the kidney. 
Rabbits  Treated  with  Intravenous  Injections  of Gt  Anti-RbACE  3,-Globulin.  1) 
Normal rabbits:  On the first day of the antibody injections the majority of the 
rabbits showed signs of respiratory distress and 69% died from pulmonary edema. 
On the following days the mortality fell dramatically (Table I) and the rabbits 
tolerated the injections of the anti-ACE 3,-globulin without overt symptoms. 
The results of IF microscopy studies of the lung are summarized in Table I. 
The deposits of GtIgG and RbC3 found along the alveolar capillary walls on the 
first 3 d  of antibody administration were granular in appearance (Figs.  1 B and 
3).  The granular pattern of binding of anti-ACE antibodies in vivo contrasted 
with the linear pattern  observed in vitro (Fig.  1A).  Furthermore, in direct IF 
microscopy the distribution of ACE in the lungs of rabbits injected with Gt anti- 
Rb ACE 3,-globulin was also granular (Fig.  1 C).  In Table I  it should be noted 
that on day 4, the last day of antibody administration, immune deposits were no 
longer detectable in the lungs (Fig. 4). In addition, when these lungs were studied 
by indirect IF microscopy it was found that ACE was absent or present in only 
minimal amounts. In lung tissue of rabbits that were sacrificed, fibrin appeared 
localized within the lumen of alveolar capillaries and, in animals that died on the 
first  day  of injection  with  pulmonary edema,  also  in  the  alveolar space.  The 
results of direct IF tests for the presence of GtlgG in selected organs other than 
the lung are presented in Table II. In the kidneys of some of the rabbits sacrificed 
on day 4 or 5, weak and ill-defined localization of GtIgG was found along the 
glomerular capillary  walls.  GtIgG was never detected on the brush border of 
proximal tubules. In the spleen granular localization of GtIgG was observed in 
perifollicular zones. Whenever GtIgG was seen in the choroid plexus (Fig. 2B) 
or  the  adrenal,  it  was  present  in  a  granular  pattern  along  the  capillary  or 
sinusoidal walls, respectively. 
Quantitative studies (Fig. 5) showed a precipitous drop in ACE activity in the 
lungs of rabbits  injected  with anti-ACE  3"-globulin.  Discontinuation of the  3"- 
globulin administration  resulted,  within  24 h,  in  a  significant  increase  in  the 
amount of ACE activity present in the lung; normal values were found on day 
21. The values of ACE activity determinations in serum paralleled those in lung. 
No change in kidney ACE activity was observed. 
In animals that died with pulmonary edema the findings by light and electron 
microscopy were similar to those described in an earlier publication (11), and 
included areas  of alveolar capillary wall degeneration and necrosis, and accu- 
mulation  in  capillary  lumina of occasionally  disintegrated  polymorphonuclear 
leukocytes, platelets, and fibrin.  The polymorphonuclear leukocytes contained 
an increased amount of glycogen (26) and glycogen granules were found free in 
vascular  lumina. Areas of frank  necrosis were absent in  lungs of rabbits  that FIGURE  1.  (A) lmmunofluorescence micrograph showing in vitro binding of Gt anti-RbACE 
IgG to alveolar capillary walls  of normal lung. The staining pattern  is linear.  X  600.  (B) 
Immunofluorescence micrograph  showing  in  vivo binding of Gt  anti-RbACE  IgG  along 
alveolar capillary walls.  The staining pattern  is granular.  ×  600.  (C)  Immunofluorescence 
micrograph showing a granular distribution of ACE after in vivo binding of Gt anti-RbACE 
IgG along alveolar capillary walls. X 600. 
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FIGURE  1  C. 
survived the first three injections of Gt anti-ACE ~,-globulin and were sacrificed 
on day  1.  In these animals the alveolar septa were not thickened; the alveolar 
endothelium, however, was markedly swollen and displayed an increased number 
of caveolae and vacuoles of variable size. In rabbits sacrificed on day 2 through 
5  the alveolar septa  were thickened.  This thickening was caused by influx of 
mononuclear and  polymorphonuclear leukocytes, proliferation  of septal  cells, 
and  the  presence of many type  II  pneumocytes.  Over days  2  through  5  the 
polymorphonculear  leukocytes  gradually  regained  their  normal  appearance. 
Many macrophages were present in the alveolar space. On day 5 the endothelium 
was  still  swollen  and  showed an  abundant  rough  endoplasmic  reticulum and 
many free ribosomes. On day 21  the lung morphology had returned to normal 
and scarring was not found. 
Rabbits injected with normal Gt 3,-globulin were sacrificed on day 1 (n =  7), 4 
(1~  =  5),  5  (~  =  1),  and  21  (n  =  2).  In these rabbits  the results of all  studies, 
including quantitation of ACE in lungs, kidneys, and sera, were normal. 
2) Polymorphonuclear leukocyte-depleted rabbits: On the first day of Gt anti- 
RbACE 3,-globulin injections, no polymorphonuclear leukocytes could be found 
in the circulation of HNz-treated rabbits.  The mortality (40%) on the first day 
in  this  group  of animals  was  not  statistically  significant  different  from  that 
observed in non-polymorphonuclear leukocyte-depleted rabbits. 
In this group of rabbits the results obtained by IF microscopy were similar to 
those  obtained  in  rabbits  nondepleted of polymorphonuclear leukocytes and 
injected with anti-ACE antibody: initially the lung immune deposits were gran- 2148  LUNG  INJURY  MEDIATED  BY  ANTIBODIES TO  ENDOTHELIUM 
FIGURE 2.  (A) Immunofluorescence micrograph showing in vitro binding of Gt anti-RbACE 
IgG to the endothelium of capillaries of the choroid plexus.  The staining  pattern is linear. 
× 250.  (B) Immunofluorescence micrograph showing in vivo binding of Gt anti-RbACE  IgG 
to the endothelium  of capillaries  of the  choroid plexus.  The staining  pattern  is  granular. 
x 400. 
TABLE  I 
Mortality and hnmunofluorescence Findings in Lungs of Rabbits Injected on Day 1 through 4 
with 21 mg of Goat Anti-rabbit Angiotensin-converting Enzyme 3,-Globulin per Day 
No. of rabbits 
Day  Mortality in  studied by DIF 
percent  microscopy 
Deposits along alveolar capillary wall: percentage 
of rabbits positive 
GtlgG  RblgG  RbC3  Rb Fibrin 
1  69  22  100  0  81  81 
2  13  7  57  0  29  71 
3  0  3  33  0  ND  ND 
4  0  5  0  0  0  20 
5  0  7  0  0  0  14 
21  0  5  0  0  0  0 
Abbreviations:  DIF, direct immunofluorescence;  Gt, goat; Rb, rabbit;  ND, not done. 
ular and, on day 4  (n =  2),  were no longer detectable.  No, or only an occasional 
polymorphonuclear  leukocyte  was  seen  after  staining  sections  of frozen  lung 
tissue of rabbits  that died on day  1 with  FITC-conjugated antiserum  to cationic 
proteins of rabbit polymorphonuclear leukocyte. 
With  the  exception  of absence  of polymorphonuclear  leukocytes  on  day  1, 
light  and  electron  microscopy  revealed  lung  lesions  similar  to  those  seen  in 
rabbits  nondepleted  of polymorphonuclear  leukocytes  and  injected  with  anti- BARBA ET AL:  2149 
FIGURE 3.  Immunofluorescence  micrograph  showing the binding of RbC3 along alveolar 
capillary walls of a rabbit injected with Gt anti-RbACE 3,-globulin. The staining pattern is 
granular. × 250. 
ACE antibody. 
hnmunoelectron Microscopy.  Injected HRP-labeled Gt anti-ACE ~,-globulin was 
found  to  be  irregularly distributed  along  the  surface of the  endothelium of 
alveolar capillaries; it was also found in endothelial caveolae and had accumulated 
in vacuoles of variable size within the endothelial cytoplasm (Fig. 6).  HRP could 
not be demonstrated in lung tissue of the control rabbits. 
Rabbits Injected with Gt Anti-RbACE IgG,  or F(ab')~ or Fab Fragments of Gt Anti- 
RbACE  IgG.  GtIgG  or  F(ab')~  fragments  injected  into  rabbits  were  found, 
together  with  RbC3,  in  a  granular  pattern  along alveolar capillary  walls.  In 
contrast, Fab fragments of Gt anti-RbACE IgG localized in a linear pattern along 
alveolar capillary walls (Fig. 7A). In direct IF microscopy the distribution of ACE 
was also linear (Fig. 7B). Complement fixation could not be detected in the lungs 
of rabbits injected with Fab fragments. 
When the injection of Fab fragments of Gt anti-RbACE IgG was followed by 
an injection of Rb anti-GtIgG serum, fine granular deposits of Gt Fab fragments 
(Fig.  7A,  inset),  RbIgG  and  RbC3  were  seen  along  alveolar  capillary  walls. 
Injection" of Fab fragments of normal GtIgG followed by Rb anti-GtIgG serum, 
did not result in formation of granular immune deposits along alveolar capillary 
walls.  However, precipitates composed of Gt Fab fragments, RbIgG, and RbC3 
were occasionally present in the lumen of alveolar capillaries. 
Rabbits to Which,  Following a Single Injection  of Gt Anti-RbACE ~-Globulin, Radio- 
labeled Rat Anti-RbABM Antibodies Were Administered.  In the rabbits injected with 2150  LUNG  INJURY  MEDIATED  BY  ANTIBODIES TO  ENDOTHELIUM 
FIGURE 4.  Immunofluorescence  micrograph showing absence of binding of GtlgG to lung 
tissue in a rabbit sacrificed on the fourth day of administration of Gt anti-RbACE -r-globulin. 
x 600. 
TABLE  II 
Localization of Goat IgG in Selected Organs of Rabbits Injected on Day 1 through 4 with 21 mg of 
Goat Anti-rabbit Angiotensin-converting Enzyme ~-Globulin per Day 
Choroid  Day  Kidney*  Spleen  Liver  Adrenal  plexus 
1  0/22  8/14  0/14  3/13  3/9 
2  0/7  3/8  0/8  0/8  2/8 
3  ND  ND  ND  ND  ND 
4  3/5  1/5  0/5  0/5  3/5 
5  3/7  2/7  0/7  0/7  2/4 
21  0/5  0/5  0/5  0/5  0/2 
* Number of organs with deposits of goat IgG over total number of organs studied. 
anti-ACE  -r-globulin  the  specific  uptake  of ~25I-rat anti-RbABM  antibodies  (as 
corrected percent  uptake of total  injected  dose of 125I) was  2.4  _+  0.8  (mean  + 
SD) in the lungs,  1 1.3 +  1.1  in the kidneys, and 31.6 +  3.7 in the liver. In rabbits 
injected  with  normal Gt ~,-globulin these  values were:  lungs 0.5  +  0.1,  kidneys 
10.7 +  0.7, and liver 36.2  -+  1.5. The only statistically significant difference was 
the increased binding of anti-ABM antibodies to the lungs in the group of rabbits 
treated with anti-ACE -r-globulin. BARBA  ET  AL.  2151 
The Effect In Robbits  Of Repeated  Intravenous  Injections  Of Gt anti- Rb 
ACE Antibodies  On The ACE Content  Of Lung,  Kidney  And Serum 
t.0 
0.5 
T  E 
"--,~  Kidney 
Serum 
"~  I 
0  ~  2  3  4  5  2t 
Ooys 
FIGURE 5.  Quantitation of ACE activity in lung, kidney, and serum. Indicated are means _+ 
2  SE.  Between parentheses, the number of rabbits studied.  Gt anti-RbACE "),-globulin  was 
administered during the time period represented as a  shaded area.  The values of lung and 
kidney ACE activity on day 0 were obtained from rabbits injected with normal Gt ~,-globulin. 
Discussion 
ACE  catalyzes  the  conversion  of angiotensin  I  into  the  potent  vasoactive 
peptide angiotensin II, and the degradation of the hypotensive and edematogenic 
peptide  bradykinin  (27-29).  Although ACE is  found on  the surface of most 
endothelial cells, a major site of ACE activity appears to be the lung (6, 7, 9, 29- 
31). Results of immunohistochemical studies show ACE on the plasma membrane 
and in caveolae of lung endothelial cells (7).  Previous studies have shown that 
rabbits  (1 l)  and rats  (31)  injected with  large doses of heterologous anti-ACE 
antibodies  develop  increased vascular  permeability in  the  lung  (31)  and  fre- 
quently die of pulmonary edema. 
The aim of the present study was to investigate the effects of a relatively long- 
term interaction of Gt anti-RbACE antibodies with lung ACE. To this purpose, 
small doses of antibody were slowly injected for a maximum of 4 d. Despite these 
precautions a high mortality, due to pulmonary edema, was recorded on the first 
day of injection.  Increased alveolar capillary wall permeability, as reflected in 
the uptake of anti-RbABM antibodies, was also found in rabbits that did not die 
from pulmonary edema, confirming an earlier observation in rats (31). The role 
of polymorphonuclear ieukocytes in the induction of increased alveolar capillary 
wall permeability does not appear essential because of mortality rate of rabbits 
depleted or not depleted of polymorphonuclear leukocytes was not significantly 
different. 
Rabbits surviving the first day of anti-ACE antibody injection, became resistant 
to subsequent administration. The suppression of immune injury appears to be 
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FIGURE 6.  Immunoelectron micrograph of lung of a  rabbit  injected with HRP-labeled Gt 
anti-RbACE v-globulin. Black HRP reaction product is seen in an irregular distribution along 
the surface of the alveolar capillary endothelium (E), in endothelial caveolae, and in vacuoles 
in the endothelial cytoplasm. The lumen of the alveolar capillary is obliterated by cytoplasm 
of an unidentified cell (large asterisk). Small asterisks: alveolar basement membrane. Unstained 
section. ×  6,000. 
interaction at  the level of the plasma membrane of endothelial cells.  Gt anti- 
RbACE antibodies bound in vitro to the endothelium of the lung with a distinctly 
linear immunofluorescence pattern, corresponding to the even distribution of 
ACE along the plasmamembrane of lung endothelial cells observed by immunoe- 
lectron microscopy (7). In contrast, after in vivo injection of the antibody, diffuse 
granular  deposits of ACE,  GtIgG,  and  RbC3  were  observed  along  alveolar 
capillary walls and also, for example, along capillary walls of the choroid plexus. 
This indicates that in vivo cross-linking of ACE molecules by divalent antibodies 
induces a migration of the enzyme in the plane of the plasma membrane, resulting 
in the formation of microaggregates (32).  This interpretation is supported by 
the observation of linear deposits along alveolar capillary walls of Gt Fab antibody 
fragments, contracting with the granular pattern observed after injection of Gt 
F(ab')2 antibody fragments. The monovalent Fab antibody fragments, although 
binding to the plasma membrane of the alveolar endothelium, did not induce 
redistribution of ACE.  Addition of a  "piggyback" antibody (Rb anti-GtIgG) to 
cross-link  the  Fab-ACE  complex,  resulted  in  antigen  redistribution.  Similar 
studies have been performed on cultures of skeletal muscle using antibodies to 
acetylcholine receptors (33-34).  It was found that, despite binding, the monov- 
alent Fab  fragments of anti-acetylcholine receptor antibodies did not enhance FmVRE 7.  (A)  Immunofluorescence micrograph  showing  in  vivo  linear binding of Fab 
fragments of Gt anti-RbACE IgG along the endothelium of alveolar capillaries, x 600. Inset: 
Immunofluorescence micrograph showing in vivo granular binding of Fab fragments of Gt 
anti-RbACE IgG along the alveolar  capillary  endothelium in a  rabbit that,  following  the 
administration  of the antibody fragments,  was injected with Rb anti-GtlgG antiserum, x 600. 
(B) Immunofluorescence  micrograph showing a linear distribution  of ACE after in vivo binding 
of Fab fragments of Gt anti-RbACE IgG along the endothelium of alveolar capillaries, x 600. 
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degradation of the receptors. However, when "piggyback" antibodies were added 
to the system, the degradation rate increased. 
In vivo cross-linking of ACE molecules by divalent antibodies led to disappear- 
ance  of ACE  from  the  surface  of lung  endothelial  cells.  Whether  ACE  was 
internalized (35), shed into the circulation (36),  or both, is not clear from our 
study. The evidence for disappearance of ACE is based on the following obser- 
vations: first, despite continued injections of Gt anti-RbACE antibodies, deposits 
of GtIgG or RbC3 were not present in the lungs of the rabbits sacrificed at day 
4; second, ACE was no longer demonstrable by indirect IF microscopy in the 
lungs of rabbits  sacrificed at  day  4;  third,  quantitative  measurement of ACE 
activity in lung homogenates showed, in agreement with the IF data, a striking 
decrease in activity of the enzyme on day 4.24 h after discontinuation of antibody 
administration, there was a reappearance of ACE activity in the lung and normal 
levels were recorded 17 d after the last antibody injection. The endothelial cells 
denuded of ACE were no longer susceptible to immune injury, as evidence by 
the sharp drop in mortality during days 2, 3, and 4 of antibody injection. The 
morphological abnormalities  found in the lungs of rabbits  sacrificed on those 
days may reflect repair processes. 
The in vivo disappearance of ACE from the surface of lung endothelial cells 
under the influence of specific antibody is an example of "antigenic modulation" 
(32).  Antigenic  modulation  was  first  described  by  Boyse  et  al.  (37,  38)  who 
showed that surface isoantigens on mouse leukemic cells disappear when the cells 
are exposed to antibodies. Such phenotypic alteration occurs in vitro as well (39), 
and is reversed  by  eliminating the antibodies.  It  has  been  demonstrated that 
antigenic modulation is an active process requiring metabolically intact cells and 
does not result from long-term masking of isoantigens by IgG (39). It was later 
shown that anti-Ig antibody can redistribute surface Ig on murine lymphocytes 
into polar aggregates ("caps") (40,  41).  After incubation of lymphocytes under 
capping  conditions,  surface  Ig  totally  disappears  through  endocytosis and/or 
external stripping. Surface Ig reappears shortly after reculturing lymphocytes in 
a  medium devoid of anti-Ig antibody.  Antibody-induced antigenic modulation 
has  also  been  demonstrated  for  histocompatibility  antigens  (42-45),  Burkitt 
lymphoma cell surface antigens (46) and Gross leukemia cell surface  antigens 
(47).  In persistent viral  infections, such as measles, infected cells express viral 
glycoprotein antigens on their surface. When exposed to anti-measles antibodies, 
however,  the  viral  antigens  rapidly  coalesce  into  a  pole of the  cell  and  then 
disappear  from  the  cell  surface,  shed  into  the  medium in  form  of immune 
complexes (48, 49). The infected cells, denuded of viral surface antigens, are no 
longer susceptible to both humoral and  ceil-mediated immune responses (50). 
Such  a  mechanism  of  antibody-induced  insensitivity  to  immunologic  injury 
appears to have a central role in the pathogenesis of subacute sclerosing panen- 
cephalitis  and  other  persistent  viral  infections  associated  with  high  antibody 
responses (36). The results of the present study show that antigenic modulation 
occurs in the lungs of rabbits injected with anti-ACE antibodies reacting with the 
plasma membrane of endothelial cells. The reappearance of ACE after suspension 
of antibody injections indicates that antigenic modulation, as in cell cultures (50), 
is at least partially reversible in vivo. It is conceivable that the expression of other BARBA  ET  AL,  2155 
antigens on  the plasma  membrane of endothelial cells may be  modulated by 
antibodies. In this regard it is attractive to consider the possibility that antigenic 
modulation  may contribute,  together with  other  factors,  to  the  resistance  to 
rejection occurring in grafts exposed to transplantation antibodies (51). Further- 
more,  it  does  not  escape  our  notice  that  patching  and  shedding  of plasma 
membrane antigens, such as those expressed on the plasma membrane of glo- 
merular visceral epithelial cells (52), might result in local accumulation of immune 
complexes (Heymann glomerulonephritis). This hypothesis is now being tested 
in our laboratory. 
To  avoid  anaphylactic complication,  the administration  of Gt  anti-ACE  y- 
globulin  had  to  be  limited to  4 d.  To  study the chronic effects of anti-ACE 
antibodies  on  lung  and  other  organs  it  will  be  necessary to  render  rabbits 
immunologically tolerant to GtIgG. 
Summary 
To  study the  effects of relatively  long-term  interaction  of antibodies  with 
surface antigens of lung endothelium, rabbits were intravenously injected for a 
maximum of 4 d  with goat anti-rabbit lung angiotensin-converting enzyme (Gt 
anti-RbACE) antibodies. On day 1 69%, on day 2  13%, and on days 3 and 4 of 
injection none of the rabbits developed lethal pulmonary edema. By immunoflu- 
orescence microscopy, deposits of GtlgG, frequently in association with RbC3, 
were found along the endothelium of alveolar capillary walls in all rabbits studied 
on day  1,  in  57%  on day 2,  in  33%  on day 3, and in none of them on day 4. 
While  in  vitro  anti-ACE  antibodies  bound  in  a  linear  pattern  to  the  lung 
endothelium, the binding pattern in  vivo was distinctly granular.  The in  vivo 
interaction of antibodies with ACE also redistributed ACE in a granular pattern 
along capillary walls. In contrast to the granular deposition of injected anti-ACE 
IgG and  F(ab')2  fragments of anti-ACE IgG,  Fab  fragments of anti-ACE IgG 
localized, without fixing C3,  in a  linear pattern along the endothelium of lung 
capillaries and did not modify the normal distribution of ACE. However, when 
the injection of Fab fragments of Gt anti-RbACE IgG was followed by an injection 
of Rb anti-GtlgG serum,  granular deposits of Gt  Fab  fragments,  RblgG  and 
RbC3 were seen along alveolar capillary walls. Biochemical measurement of ACE 
activity in lung homogenates provided data in agreement with those obtained by 
immunofluorescence microscopy, showing diminished activity to none on day 4, 
with  some return  of ACE  activity  on  day  5,  24 h  after  the  last  injection  of 
antibody,  and  normal  values  on  day  21.  The  results  obtained  indicate  that 
divalent antibodies to an antigen expressed on the plasma membrane of rabbit 
lung endothelial  cells promotes a  rapid  redistribution  of antigenic receptors, 
fixation of complement and, in surviving rabbits,  disappearance of the antigen 
from the endothelial cells that are no longer susceptible to immune injury. In 
vivo "immunologic enzymectomy" induced by a  ligand-surface antigen interac- 
tion is an example of antigenic modulation. These events may have an important 
role in the pathogenesis of inflammatory lesions induced by antibodies reacting 
with antigens expressed on  the plasma membrane of cells in  the lung and in 
other organs. 2156  LUNG  INJURY MEDIATED BY  ANTIBODIES  TO  ENDOTHELIUM 
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